Tissue Plasminogen Activator Market Estimated to Witness Growth Owing to Increasing Demand for Non-invasive Treatment Options
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBdnl_NpPHtRF_v1VXXFBnXt-_e3dAyoZkQFhfdRBRhGYEnIu90p-pqiJOxr9JKQ4bmv9B-MZ0-aTxdHN1YqcNkg2NuJuzNp5aYe6aLu7qGs1I4iVQHd0NjtowPi9591SSW8Qlnl8TZz4WELvM5O6K8fhcKrLgzvp5-aG33osJhgubPqfg9hClKzSB7RI/w400-h265/Tissue%20Plasminogen%20Activator.jpg)
Tissue Plasminogen Activator Market Trends The tissue plasminogen activator market is witnessing significant demand owing to the increasing prevalence of cardiovascular diseases such as heart attack, deep vein thrombosis, pulmonary embolism and stroke. Tissue plasminogen activator is a thrombolytic agent, with high fibrin specificity, used to dissolve clots and restore blood flow in acute myocardial infarction, ischemic stroke or massive pulmonary embolism. It provides an effective alternative to surgery for non-invasive treatment of conditions caused by blood clots. The global tissue plasminogen activator market is estimated to be valued at US$ 614.9 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period from 2024 to 2030. The increasing demand for minimally invasive procedures and advantages of tissue plasminogen activator such as improved survival rates, reduced bleeding complications and hospital stay are supporting market growth. Key Takeaways Key pl